4//SEC Filing
GKCC, LLC 4
Accession 0000950170-24-034198
CIK 0001601485other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:28 PM ET
Size
7.5 KB
Accession
0000950170-24-034198
Insider Transaction Report
Form 4
Chudnovsky Yekaterina
Director10% Owner
Transactions
- Purchase
Pre-Funded Common Stock Purchase Warrant
2024-03-19$5.81/sh+1,032,702$5,999,999→ 1,032,702 total(indirect: By LLC)Exercise: $0.01→ Common Stock (1,032,702 underlying)
GKCC, LLC
10% Owner
Transactions
- Purchase
Pre-Funded Common Stock Purchase Warrant
2024-03-19$5.81/sh+1,032,702$5,999,999→ 1,032,702 total(indirect: By LLC)Exercise: $0.01→ Common Stock (1,032,702 underlying)
Footnotes (3)
- [F1]Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained.
- [F2]The Pre-Funded Warrants do not have an expiration date.
- [F3]Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001977769
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:28 PM ET
- Size
- 7.5 KB